Annual Lung SPORE Workshop (Abstract Submission): Submission #28

serial: '28'
sid: '110455'
uuid: 02484ac5-ffc7-4add-b2ba-24f704b046ae
uri: /dctd/lungsporemeeting/abstracts
created: '1710116749'
completed: '1710116749'
changed: '1715365081'
in_draft: '0'
current_page: ''
remote_addr: 10.208.28.228
uid: '0'
langcode: en
webform_id: lung_spore_investigator_abstract
entity_type: node
entity_id: '1171'
locked: '0'
sticky: '0'
notes: ''
data:
  additional_authors_list: {  }
  topic_classification:
    - 'Session 1: Oncogene-driven lung cancers and resistance to targeted therapies'
  abstract_review_status: 'Approved to be a Speaker'
  abstract_title: 'Systematic discovery of osimertinib resistance variants using CRISPR prime editing'
  affiliation_author1: 'Fred Hutch'
  affiliation_presenter: 'Fred Hutch'
  email: ahberger@fredhutch.org
  first_name: Alice
  first_name_author1: Alice
  last_name: Berger
  last_name_author1: Berger
  phone: '2066676281'
  poster_uploaded: ''
  special_characters_included_: '0'
  upload_abstract_1: '44440'
  upload_poster: ''